Bone deposition, bone resorption, and osteosarcoma

@article{Toledo2010BoneDB,
  title={Bone deposition, bone resorption, and osteosarcoma},
  author={Silvia Regina Caminada Toledo and Indhira Dias Oliveira and Oswaldo Keith Okamoto and Marco Antonio Zago and Maria Teresa de Seixas Alves and Reynaldo Jesus Garcia Filho and Carla Renata Pacheco Donato Macedo and Ant{\^o}nio S{\'e}rgio Petrilli},
  journal={Journal of Orthopaedic Research},
  year={2010},
  volume={28}
}
Bone deposition and bone resorption are ongoing dynamic processes, constituting bone remodeling. [...] Key Method We used real-time PCR to evaluate the mRNA levels of the tartrate-resistant acid phosphatase (ACP5), colony stimulating factor-1 (CSF1R), bone morphogenetic protein 7 (BMP7), collagen, type XI, alpha 2 (COL11A2), and protein tyrosine phosphatases zeta 1 (PTPRZ1) genes, in 30 OS tumor samples and correlated with clinical and histological data. All genes analyzed, except CSF1R, were differentially…Expand
Clinical significance of bone morphogenetic protein in osteosarcoma: A systematic review
TLDR
Endogenous BMP or BMP receptor expression may be associated with osteosarcoma metastasis but are of uncertain prognostic significance, and any harmful or beneficial effects of exogenous therapeutic BMP application in this setting are unproven. Expand
The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
TLDR
Some early genetic events such as the loss of RANKL and the gain of CXCR4 expressions probably facilitate the metastatic progression concomitant with the primary tumor establishment, supporting the role of the CX CR4 receptor in directing osteosarcoma metastases to the lung. Expand
The role of pleiotrophin in bone repair.
TLDR
Pleiotrophin (PTN), also called osteoblast-specific factor 1, is a heparin-binding angiogenic growth factor, with a well-defined and significant role in both physiological and pathological angiogenesis. Expand
Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma.
TLDR
The results validated the POS-1 orthotopic model as "OS imaging model," that could serve for evaluating in vivo therapies targeting tumor proliferation and/or bone remodeling in OS. Expand
MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.
TLDR
The data indicated that MAPK7 gene expression associated with genotype exchange after chemotherapy, and these SNPs associated with important clinical parameters might be a valuable indicator for predicting in OS. Expand
MAPK7 and MAP2K4 as prognostic markers in osteosarcoma.
TLDR
Overexpression of these genes was significantly associated to a poor response to treatment, tumor progression, and worse overall survival, suggesting that MAPK7 and MAP2K4 could play an important role in osteosarcoma tumorigenesis. Expand
MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2
TLDR
The view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells is supported, and this increase positively correlated with the transfection concentration of miR -144 mimics. Expand
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
TLDR
The different actors of the osteosarcoma microenvironment are described and an overview of the past, current, and future strategies of therapy targeting this complex ecosystem is given, with a focus on the role of extracellular vesicles and on the emergence of multi-kinase inhibitors. Expand
Influence of BONITmatrix(®) and OSSA NOVA on the expression of bone specific genes.
TLDR
It can be stated that only the granular dosage form of BONITmatrix(®) is able to stimulate osteoblast differentiation, whereas OSSA NOVA has no influence on the gene expression of osteoblasts. Expand
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.
TLDR
This review provides an overview concerning current RTK-mediated therapies in OS and ES and describes several strategies to overcome resistance to RTK inhibitors which may significantly improve outcome of OS andES patients. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
Bone morphogenetic proteins in bone tumors
TLDR
Clinically, BMPs have utility as diagnostic and prognostic markers for characterizing the stage of differentiation of mesenchymal cells and meschymal tumors, and they may be of value in predicting the prognosis of sarcoma patients. Expand
The new bone biology: pathologic, molecular, and clinical correlates.
  • M. Cohen
  • Biology, Medicine
  • American journal of medical genetics. Part A
  • 2006
Bone and cartilage and their disorders are addressed under the following headings: functions of bone; normal and abnormal bone remodeling; osteopetrosis and osteoporosis; epithelial-mesenchymalExpand
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
TLDR
A vicious cycle model is confirmed at the molecular level driving the formation of osteolytic metastases: tumor cells secrete factors stimulating osteoclasts through adjacent bone marrow stromal cells; osteoclastic resorption in turn releases growth factors from the bone matrix; finally, locally released growth factors activate the tumor cells. Expand
Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?
TLDR
The basic science supporting the putative roles of common, relatively safe but disparate agents-ranging from caffeine and theophylline to dextromethorphan and econazole-in the potential treatment of osteoblastic osteosarcoma is reviewed. Expand
Regulatory mechanisms of osteoblast and osteoclast differentiation.
TLDR
The discovery of Smad-mediated signals revealed the precise functions of BMPs in osteoblast differentiation and confirmed the well-known hypothesis that osteoblasts play an essential role in osteoclast differentiation. Expand
Extracellular matrix gene regulation.
Extracellular matrix metabolism plays a central role in development of skeletal tissues and in most orthopaedic diseases and trauma such as fracture or osteotomy repair, arthritis, cartilage repair,Expand
Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells.
TLDR
The results suggest the presence of a mechanism involving the simultaneous activation of the BMPs and their receptors in osteosarcoma cell lines, which is related to poor prognosis in malignant and metastatic bone tumors. Expand
Expression of bone resorption genes in osteoarthritis and in osteoporosis
TLDR
Gene expression of cathepsin K, MMP-9, TRAP, RANKL, OPG, and osteocalcin and the association between their mRNA levels pointed to higher bone resorption and bone formation in osteoarthritis, differences in balance between them, and differences in regulation of bone resOrption in osteOarthritic and osteoporotic bone. Expand
Expression of bone morphogenetic proteins and receptors in sarcomas.
TLDR
The ligands for bone morphogenetic protein receptors, bone morphogenic proteins-2, -4, and -6 also are expressed in osteosarcoma and other sarcoma tissues, indicating a potential for autocrine or paracrine growth stimulation in these tumors. Expand
Review of Cellular Mechanisms of Tumor Osteolysis
TLDR
Findings suggest that production of macrophage colony stimulating factor may be required for tumor osteolysis to occur with some tumors, and attempts to identify tumor cell products that regulate these cellular mechanisms are in progress. Expand
...
1
2
3
4
5
...